Grown Rogue International (GRUSF) Revenue Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Revenue Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 2.22% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 4.22% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.31% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 9.51% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -1.40% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 28.43% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.98% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 161.16% |
| Jul 31, 2023 | 138.74% |
| Apr 30, 2023 | 72.36% |
| Jan 31, 2023 | 59.99% |
| Jan 31, 2022 | 64.78% |
| Oct 31, 2021 | 68.20% |
| Jul 31, 2021 | 64.54% |
| Apr 30, 2021 | 74.20% |
| Jan 31, 2021 | 83.20% |
| Aug 31, 2017 | -11.22% |
| May 31, 2017 | -44.99% |
| Aug 31, 2015 | 29.49% |
| Feb 28, 2015 | 5.95% |
| Nov 30, 2014 | 1.41% |
| Aug 31, 2014 | 4.09% |
| May 31, 2014 | 15.97% |
| Feb 28, 2014 | -15.57% |
| Nov 30, 2013 | -1.47% |
| Aug 31, 2013 | -5.67% |
| May 31, 2013 | -19.08% |